These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31415861)

  • 1. Prevalence of Left Ventricular Systolic Dysfunction in Myotonic Dystrophy Type 1: A Systematic Review.
    Russo V; Sperlongano S; Gallinoro E; Rago A; Papa AA; Golino P; Politano L; Nazarian S; Nigro G
    J Card Fail; 2020 Oct; 26(10):849-856. PubMed ID: 31415861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased mortality with left ventricular systolic dysfunction and heart failure in adults with myotonic dystrophy type 1.
    Bhakta D; Groh MR; Shen C; Pascuzzi RM; Groh WJ
    Am Heart J; 2010 Dec; 160(6):1137-41, 1141.e1. PubMed ID: 21146669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of atrial fibrillation in myotonic dystrophy type 1: A systematic review.
    Russo V; Papa AA; Lioncino M; Rago A; Di Fraia F; Palladino A; Politano L; Golino P; Nigro G
    Neuromuscul Disord; 2021 Apr; 31(4):281-290. PubMed ID: 33573883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Routine echocardiography in patients with myotonic dystrophy type 1.
    Paunic T; Peric S; Cvitan E; Raspopovic S; Peric M; Mandic Stojmenovic G; Rakocevic Stojanovic V
    J Chin Med Assoc; 2017 Jul; 80(7):408-412. PubMed ID: 28601625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Circumferential and Longitudinal Left Ventricular Systolic Dysfunction in Patients with Rheumatoid Arthritis without Overt Cardiac Disease.
    Cioffi G; Viapiana O; Ognibeni F; Dalbeni A; Gatti D; Mazzone C; Faganello G; Di Lenarda A; Adami S; Rossini M
    J Am Soc Echocardiogr; 2016 Jul; 29(7):689-98. PubMed ID: 26922258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Apical left ventricular myocardial dysfunction is an early feature of cardiac involvement in myotonic dystrophy type 1.
    Garcia R; Labarre Q; Degand B; Ingrand P; Le Gal F; Bonnet B; Delaubier A; Guillou C; Gellen B; Coisne D; Bouleti C; Christiaens L
    Echocardiography; 2017 Feb; 34(2):184-190. PubMed ID: 28191665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Left Ventricular Systolic Dysfunction and Heart Failure in the Framingham Study: An Echocardiographic Study Over 3 Decades.
    Vasan RS; Xanthakis V; Lyass A; Andersson C; Tsao C; Cheng S; Aragam J; Benjamin EJ; Larson MG
    JACC Cardiovasc Imaging; 2018 Jan; 11(1):1-11. PubMed ID: 28917679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of cardiac involvement in patients with myotonic dystrophy type 1: a cross-sectional study.
    Petri H; Witting N; Ersbøll MK; Sajadieh A; Dunø M; Helweg-Larsen S; Vissing J; Køber L; Bundgaard H
    Int J Cardiol; 2014 Jun; 174(1):31-6. PubMed ID: 24704412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated plasma levels of cardiac troponin-I predict left ventricular systolic dysfunction in patients with myotonic dystrophy type 1: A multicentre cohort follow-up study.
    Hamilton MJ; Robb Y; Cumming S; Gregory H; Duncan A; Rahman M; McKeown A; McWilliam C; Dean J; Wilcox A; Farrugia ME; Cooper A; McGhie J; Adam B; Petty R; ; Longman C; Findlay I; Japp A; Monckton DG; Denvir MA
    PLoS One; 2017; 12(3):e0174166. PubMed ID: 28323905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased heterogeneity of ventricular repolarization in myotonic dystrophy type 1 population.
    Russo V; Papa AA; Rago A; D'Ambrosio P; Cimmino G; Palladino A; Politano L; Nigro G
    Acta Myol; 2016 Oct; 35(2):100-106. PubMed ID: 28344440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry.
    Velazquez EJ; Francis GS; Armstrong PW; Aylward PE; Diaz R; O'Connor CM; White HD; Henis M; Rittenhouse LM; Kilaru R; van Gilst W; Ertl G; Maggioni AP; Spac J; Weaver WD; Rouleau JL; McMurray JJ; Pfeffer MA; Califf RM;
    Eur Heart J; 2004 Nov; 25(21):1911-9. PubMed ID: 15522470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of left ventricular systolic dysfunction and heart failure with reduced ejection fraction in men and women with type 2 diabetes mellitus: a systematic review and meta-analysis.
    Bouthoorn S; Gohar A; Valstar G; den Ruijter HM; Reitsma JB; Hoes AW; Rutten FH;
    Cardiovasc Diabetol; 2018 Apr; 17(1):58. PubMed ID: 29669564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of atrio-ventricular conduction disease, long-term outcomes in patients with myotonic dystrophy types I and II.
    Ha AH; Tarnopolsky MA; Bergstra TG; Nair GM; Al-Qubbany A; Healey JS
    Pacing Clin Electrophysiol; 2012 Oct; 35(10):1262-9. PubMed ID: 22385162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left Ventricular Ejection Fraction and Clinically Defined Heart Failure to Predict 90-Day Functional Outcome After Ischemic Stroke.
    Li Y; Fitzgibbons TP; McManus DD; Goddeau RP; Silver B; Henninger N
    J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):371-380. PubMed ID: 30396839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural myocardial involvement in adult patients with type 1 myotonic dystrophy.
    Dhand UK; Raja F; Aggarwal K
    Neurol Int; 2013 Feb; 5(1):e5. PubMed ID: 23717784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of all-cause heart failure and borderline left ventricular systolic dysfunction: 5 year mortality follow-up of the Echocardiographic Heart of England Screening Study (ECHOES).
    Hobbs FD; Roalfe AK; Davis RC; Davies MK; Hare R;
    Eur Heart J; 2007 May; 28(9):1128-34. PubMed ID: 17459902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supraventricular and Ventricular Arrhythmias Are Related to the Type of Myotonic Dystrophy but Not to Disease Duration or Neurological Status.
    Bienias P; Łusakowska A; Ciurzyński M; Rymarczyk Z; Irzyk K; Kurnicka K; Kamińska A; Pruszczyk P
    Pacing Clin Electrophysiol; 2016 Sep; 39(9):959-68. PubMed ID: 27444982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association Between Mutation Size and Cardiac Involvement in Myotonic Dystrophy Type 1: An Analysis of the DM1-Heart Registry.
    Chong-Nguyen C; Wahbi K; Algalarrondo V; Bécane HM; Radvanyi-Hoffman H; Arnaud P; Furling D; Lazarus A; Bassez G; Béhin A; Fayssoil A; Laforêt P; Stojkovic T; Eymard B; Duboc D
    Circ Cardiovasc Genet; 2017 Jun; 10(3):. PubMed ID: 28611030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Manifestations of Myotonic Dystrophy in a Pediatric Cohort.
    Brunet Garcia L; Hajra A; Field E; Wacher J; Walsh H; Norrish G; Manzur A; Muntoni F; Munot P; Robb S; Quinlivan R; Scoto M; Baranello G; Sarkozy A; Starling L; Kaski JP; Cervi E
    Front Pediatr; 2022; 10():910660. PubMed ID: 35757141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of three-dimensional speckle tracking in the assessment of left atrial and ventricular dysfunction in patients with myotonic dystrophy type 1.
    Guedes H; Moreno N; Dos Santos RP; Marques L; Seabra D; Pereira A; Andrade A; Pinto P
    Rev Port Cardiol (Engl Ed); 2018 Apr; 37(4):333-338. PubMed ID: 29650434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.